BioXcel Therapeutics BTAIQ Insider Ownership

OTC BTAIQ

$0.03 -0.01 (-25.00%)

At close: Oct 15, 2026 · 4:00 PM EDT

Insider Holdings by Owner

208.49K Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

2.20%

■0% pp QoQ

Shares Held by Insiders

688.83K

filed for Sep 2026

■0.00% QoQ

Shares Outstanding

31.31Mn

31,305,000 shares

Direct Holdings

208.49K

Indirect: 480.34K

Net Shares Traded (QoQ)

no net change in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

Over the past 12 months, BioXcel Therapeutics insiders sold $35,646 of stock on the open market (32.82K shares) and made no open-market purchases.

By number of insiders, BioXcel Therapeutics saw 3 insiders sell on the open market over the past 12 months and none buy.
Vimal Mehta (CEO and President) sold the most BioXcel Therapeutics stock on the open market over the past 12 months, $21,108 (19.42K shares), most recently on May 20, 2026.
Outside the open market, BioXcel Therapeutics insiders acquired 97.11K shares through option exercises and conversions over the past 12 months.
According to Business Quant data, insiders at BioXcel Therapeutics reported 688.83K shares in total in their latest Form 4 filings, or 2.20% of the 31.3Mn shares outstanding; that total is unchanged from 688.83K shares at the end of Q2 2026 and up 19.16% from 578.05K shares at the end of Q3 2025.
Of the 688.83K shares held by BioXcel Therapeutics insiders, 208.49K shares (30.27%) are held directly and 480.34K shares (69.73%) indirectly, through trusts, partnerships, family members and other entities.
BTAIQ's insider total is spread across 7 insiders who have filed a Form 4 in the past two years.
BioXcel Therapeutics' top three insider holders by shares held are Vimal Mehta (CEO and President, 550.16K shares), Javier Rodriguez (Officer, 26.84K shares) and Richard I. Steinhart (Chief Financial Officer, 26.34K shares).
The largest insider, Vimal Mehta, holds 79.87% of BTAIQ's insider total.
A total of 33 Form 4 filings with transactions in BioXcel Therapeutics stock were made over the past 12 months, by 12 insiders.
The insider data for BTAIQ reflects Form 4 filings through August 14, 2026.

Form 4 Holdings

Insiders Holding BTAIQ

Insiders 7

Shares held 208.49K

Of outstanding 0.666%

#	Insider	Position	Direct	Total	Share of Insiders	Last Filed
1	Vimal Mehta	Ceo And President	69,817	69,817	33.5%	17 Jun, 2026
2	Javier Rodriguez	Officer	26,838	26,838	12.9%	17 Jun, 2026
3	Richard I Steinhart	Chief Financial Officer	26,335	26,335	12.6%	17 Jun, 2026
4	Frank Yocca	Chief Scientific Officer	26,210	26,210	12.6%	17 Jun, 2026
5	David J. Mack	Director	20,317	20,317	9.7%	03 Nov, 2025
6	Vincent O'Neill	Chief Medical Officer	19,957	19,957	9.6%	17 Dec, 2024
7	Matthew T. Wiley	Chief Commercial Officer	19,011	19,011	9.1%	03 Oct, 2024

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

554 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
12 Aug, 2026	Susan E. Atkins	Director	Acquired A	17,000	$0.00	$0	17,000	Direct
15 Jun, 2026	Richard I Steinhart	Chief Financial Officer	Acquired M	35	—	—	26,335	Direct
15 Jun, 2026	Frank Yocca	Chief Scientific Officer	Acquired M	35	—	—	26,210	Direct
15 Jun, 2026	Vimal Mehta	Ceo And President	Acquired M	219	—	—	69,817	Direct
15 Jun, 2026	Javier Rodriguez	Officer	Acquired M	35	—	—	26,838	Direct
15 Jun, 2026	Frank Yocca	Chief Scientific Officer	Disposed M	35	$0.00	$0	212	Direct
15 Jun, 2026	Richard I Steinhart	Chief Financial Officer	Disposed M	35	$0.00	$0	212	Direct
15 Jun, 2026	Javier Rodriguez	Officer	Disposed M	35	$0.00	$0	212	Direct
15 Jun, 2026	Vimal Mehta	Ceo And President	Disposed M	219	$0.00	$0	1,313	Direct
04 May, 2026	Javier Rodriguez	Officer	Acquired M	17,500	—	—	33,363	Direct
04 May, 2026	Richard I Steinhart	Chief Financial Officer	Acquired M	17,500	—	—	33,145	Direct
04 May, 2026	Vimal Mehta	Ceo And President	Acquired M	49,758	—	—	89,017	Direct
04 May, 2026	Frank Yocca	Chief Scientific Officer	Acquired M	17,500	—	—	33,020	Direct
20 May, 2026	Richard I Steinhart	Chief Financial Officer	Disposed S	6,845	$1.09	$7.43K	26,300	Direct
20 May, 2026	Javier Rodriguez	Officer	Disposed S	6,560	$1.08	$7.11K	26,803	Direct
20 May, 2026	Frank Yocca	Chief Scientific Officer	Disposed S	6,845	$1.09	$7.43K	26,175	Direct
20 May, 2026	Vimal Mehta	Ceo And President	Disposed S	19,419	$1.09	$21.11K	69,598	Direct
04 May, 2026	Richard I Steinhart	Chief Financial Officer	Disposed M	17,500	$0.00	$0	52,500	Direct
04 May, 2026	Javier Rodriguez	Officer	Disposed M	17,500	$0.00	$0	52,500	Direct
04 May, 2026	Frank Yocca	Chief Scientific Officer	Disposed M	17,500	$0.00	$0	52,500	Direct

Showing 1 to 20 of 554 transactions